International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer

Autor: Canto MI, Harinck F, Hruban RH, Offerhaus GJ, Poley JW, Kamel I, Nio Y, Schulick RS, Bassi C, Kluijt I, Levy MJ, Chak A, Fockens P, Goggins M, Bruno M, International Cancer of Pancreas Screening (CAPS) Consortium, Arcidiacono P.G., (Milan, Italy), Detlef Bartsch (Marburg, Germany), Katharina Biermann (Rotterdam, The Netherlands), Terri Brentnall (Washington, USA), Amitabh Chak (Ohio, Petr Dite (Brno, Czech Republic), Timothy Donahue (California, Dayna Early (Missouri, James Farrell (California, Carlos Fernandez-Del Castillo (Massachusetts, Harold Frucht (New York, Noriyoshi Fukushima (Tochigi, Japan), Jenny Geurts (Wisconsin, Pascal Hamell (Clichy, France), Julio Iglesias-Garcia (Santiago de Compostela, Spain), Alison Klein (Maryland, Guenter Kloeppel (Munich, Jesse Lachter (Haifa, Israel), Peter Langer (Marburg, Jeffrey Lee (Texas, Michael Levy (Minnesota, Hiroyuki Maguchi (Sapporo, Daniel Margolis (Los Angeles, Takao Ohtsuka (Fukuoka, Sara Olson (New York, NY), Gloria Petersen (Minnesota, Thomas Savides (California, Sapna Syngal (Massachusetts, Eric Tamm (Texas, Masao Tanaka (Fukuoka, Hans Vasen (Leiden, Anja Wagner (Erasmus, Huamin Wang (Texas, David Williams (Sydney, Australia), Kenjii Yamao (Nagoya

Publikováno v: Gut, 62(3), 339-347
Gut, 62(3), 339-347. BMJ Publishing Group
Gut, 62(3), 339. BMJ Publishing Group

Background Screening individuals at increased risk for pancreatic cancer (PC) detects early, potentially curable, pancreatic neoplasia. Objective To develop consortium statements on screening, surveillance and management of high-risk individuals with

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36785dd73e00061e39e3405b4d35b313
https://hdl.handle.net/1765/66852